Growing community of inventors

Schriesheim, Germany

Olaf Witt

Average Co-Inventor Count = 4.15

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Olaf WittJean Rommelaere (2 patents)Olaf WittBarbara Leuchs (2 patents)Olaf WittRalf Heinrich (12 patents)Olaf WittKarsten Geletneky (2 patents)Olaf WittChristel Herold-Mende (2 patents)Olaf WittJoerg Schlehofer (2 patents)Olaf WittJeannine Lacroix (2 patents)Olaf WittElisabeth Hedwig Deubzer (2 patents)Olaf WittSonja Kern (2 patents)Olaf WittHedwig Elisabeth Deubzer (1 patent)Olaf WittJörg Schlehofer (1 patent)Olaf WittFrank Westermann (1 patent)Olaf WittVolker Ehemann (1 patent)Olaf WittGabi Roenndahl (0 patent)Olaf WittOlaf Witt (3 patents)Jean RommelaereJean Rommelaere (33 patents)Barbara LeuchsBarbara Leuchs (14 patents)Ralf HeinrichRalf Heinrich (12 patents)Karsten GeletnekyKarsten Geletneky (12 patents)Christel Herold-MendeChristel Herold-Mende (5 patents)Joerg SchlehoferJoerg Schlehofer (4 patents)Jeannine LacroixJeannine Lacroix (2 patents)Elisabeth Hedwig DeubzerElisabeth Hedwig Deubzer (2 patents)Sonja KernSonja Kern (2 patents)Hedwig Elisabeth DeubzerHedwig Elisabeth Deubzer (1 patent)Jörg SchlehoferJörg Schlehofer (1 patent)Frank WestermannFrank Westermann (1 patent)Volker EhemannVolker Ehemann (1 patent)Gabi RoenndahlGabi Roenndahl (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Deutsches Krebsforschungszentrum (2 from 155 patents)

2. Ruprecht-Karls-Universitaet Heidelberg (2 from 23 patents)

3. Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts (1 from 160 patents)

4. Ruprecht-Karls-Universitat Heidelberg (63 patents)


3 patents:

1. 10525091 - Use of parvovirus for eliminating cancer stem cells (CSCs)

2. 9700588 - Use of parvovirus for eliminating cancer stem cells (CSCs)

3. 8361955 - Methods for treating and preventing brain tumors based on bone morphogenetic proteins

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/13/2026
Loading…